The Times of India  May 30  Comment 
Sun Pharma today reported a consolidated net profit of Rs 888.05 crore for the fourth quarter ended March 31, 2015.
The Hindu Business Line  May 29  Comment 
However, synergies from Ranbaxy’s product portfolio, improved field force productivity and presence in emerging markets should hold Sun Pharma in good stead.
GenEng News  May 29  Comment 
By now, it has become readily apparent to most that protracted exposure to the sun and UV rays leads to increased incidences of skin cancer, with melanoma leading the way as the most deadly form. What has had scientists perplexed in recent years...
The Economic Times  May 29  Comment 
Sarda says that the way both Sun and Ranbaxy have structured themselves makes him believe that they should be able to integrate things 12 months.
The Economic Times  May 28  Comment 
'Sun Pharma Ltd. is a 'SELL' call with a target of Rs 944 and a stop loss of Rs 983'
Forbes  May 27  Comment 
Over the past 25 years, the consensus investment view has been to avoid the Japanese market in favor of other geographic regions. Until recently, there was an entire Japanese generation that had not witnessed a bull market. As Japan is now...
OilVoice  May 27  Comment 
The board of directors of Sunshine Oilsands Ltd. HKEX 2012 TSX SUO is pleased to announce that it has unanimously approved and appointed Mr. Kwok Ping Sun as a nonexecutive director of the Corpo
The Economic Times  May 27  Comment 
'Sun TV is a 'BUY' call with a target of Rs 386 and a stop loss of Rs 367'
Mondo Visione  May 26  Comment 
The Securities and Futures Commission (SFC) has banned Ms Sun Xiao from re-entering the industry for 13 months from 22 May 2015 to 21 June 2016 after the Securities and Futures Appeals Tribunal (SFAT) affirmed the SFC’s decision and ordered...

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki